{
    "title": "Sarepta surges after FDA panel backs Duchenne gene therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12085197/Sarepta-surges-FDA-panel-backs-Duchenne-gene-therapy.html",
    "date": "2023-05-15",
    "keywords": [
        "approval",
        "gene",
        "therapy",
        "companys",
        "analyst",
        "premarket",
        "monday",
        "vote",
        "trading",
        "sarepta",
        "backing",
        "health",
        "certainty",
        "disorder",
        "food",
        "drug",
        "administration",
        "company",
        "duchenne",
        "dystrophy",
        "dmd",
        "srp9001",
        "panel",
        "concordance",
        "agency",
        "application",
        "joseph",
        "staff",
        "week",
        "data",
        "midstage",
        "trial",
        "evidence",
        "td",
        "interest",
        "peter",
        "march",
        "regulator",
        "use",
        "efficacy",
        "proof",
        "benefit",
        "fda",
        "advice",
        "expert",
        "decision",
        "chance",
        "engagement",
        "development",
        "review",
        "process",
        "blair",
        "tim",
        "lugo",
        "note",
        "nature",
        "stock",
        "friday",
        "meeting",
        "reporting",
        "aditya",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}